Breathing is generated automatically by brainstem circuits, then adjusted by chemical signals, voluntary commands and reflexes from working muscles. For a breathless patient, ask which input is driving ventilation and whether the output matches the need.
The preBötzinger complex in the medulla is central to inspiratory rhythm generation. Parafacial circuits contribute to active expiration. These interacting networks are more specific than the classical regions in the illustration.
Dyspnea adds perception. Respiratory motor command and sensory feedback contribute to breathing discomfort. Gas exchange and symptom intensity can diverge.
Congenital central hypoventilation syndrome combines alveolar hypoventilation with autonomic dysregulation. Most patients have a pathogenic PHOX2B variant, but rare non-PHOX2B forms are recognized. Specialist evaluation integrates phenotype and genetic testing.
Central neurogenic hyperventilation was described in 1959 in patients with brainstem disease. In practice it is reached only after more common causes of hyperventilation have been excluded (chapter 5).
Related guides: Ventilator Management, Cardiopulmonary Exercise Testing and Pulmonary Embolism & VTE.
At a fixed PCO₂, the ventilatory response to falling oxygen becomes much steeper around an alveolar PO₂ of 50–60 mmHg. This is a descriptive range, not an on–off threshold or a rule for excluding cardiopulmonary disease.
Marker follows the resting-PCO₂ curve. Timing is illustrative.
In a breathless patient with a high respiratory rate, read pH and bicarbonate first to distinguish primary hyperventilation from metabolic compensation. Then consider the direction of the PaCO₂ and the size of the alveolar–arterial (A–a) oxygen gradient.
| A–a gradient normal for age | A–a gradient widened | |
|---|---|---|
| PCO₂ low | Consider increased drive or metabolic compensationConsider metabolic acidosis, CNS disease, pain, sepsis, salicylates, pregnancy or hepatic disease. Anxiety is a diagnosis of exclusion. | Consider gas-exchange impairment plus increased driveLung or pulmonary vascular disease: embolism, interstitial disease, pneumonia, edema, shunt. |
| PCO₂ high | Consider alveolar hypoventilationNeuromuscular weakness, drug or brainstem depression, obesity or chest-wall restriction. | Consider combined gas-exchange and ventilatory failureCOPD, severe asthma or advanced parenchymal disease. Fatigue is only one possible contributor. |
Reference values vary. Hardie reported mean PaO₂ of 77.0 mmHg in men and 73.5 mmHg in women among 146 healthy adults over 70. These population means do not validate an upper-limit formula for an individual.
| Pitfall | What to do |
|---|---|
| Supplemental oxygen | Document the oxygen device and FiO₂. Nasal-cannula FiO₂ is uncertain, and the room-air age rule does not apply reliably on oxygen. Do not withdraw needed oxygen to calculate a gradient. |
| Altitude or weather | Use the actual barometric pressure rather than 760 mmHg. |
| Choice of formula | Several age equations exist. Treat the expected value as an estimate, not a diagnostic exclusion threshold. |
| Masked widening | A normal PaO₂ can coexist with a widened gradient when a low PaCO₂ has raised the alveolar PO₂. Compute the gradient rather than judging PaO₂ alone. |
In some patients with chronic lung disease, giving oxygen raises PaCO₂. The long-taught explanation, that oxygen removes the hypoxic drive and the patient stops breathing, is not supported as the main mechanism, and the response to hypoxemia is still titrated oxygen.
Austin and colleagues used cluster randomization of paramedics to give either 8–10 L/min oxygen by non-rebreather mask or oxygen titrated to a saturation of 88–92% in 405 patients with a presumed COPD exacerbation (214 with confirmed COPD). Mortality was 9% on the high-flow regimen and 4% on titrated oxygen (relative risk 0.42, 95% CI 0.20–0.89), and 9% versus 2% in confirmed COPD (relative risk 0.22, 0.05–0.91). Lower acidosis and hypercapnia were found in the small per-protocol blood-gas subgroup. These secondary outcomes did not differ significantly in the intention-to-treat analysis.
Grade the evidence honestly. The 2020 Cochrane review found this to be the only eligible trial and judged the evidence low-certainty, with unclear to high risk of bias.
A low PaCO₂ shows that effective alveolar ventilation is high relative to CO₂ production. It does not by itself identify why the patient is breathless.
Renal adaptation to sustained hypocapnia lowers bicarbonate. A coexisting metabolic acidosis can also lower it. Review the clinical time course, electrolytes, anion gap, lactate, renal function and relevant exposures before attributing the bicarbonate entirely to compensation or using it to date the disorder.
When breathlessness persists after the obvious chest testing, combine symptoms, examination, pretest probability and blood-gas physiology to choose the next test.
| If the gas shows | Consider | Related guides |
|---|---|---|
| Low PCO₂, widened gradient | Lung or pulmonary vascular disease: embolism, pulmonary hypertension, interstitial disease, edema, shunt. | Pulmonary Embolism & VTE, Pulmonary Hypertension, CPET |
| Low PCO₂, normal gradient | Metabolic compensation or increased drive: sepsis, salicylates, pregnancy, hepatic disease, pain, CNS disease or anxiety after exclusion of other causes. PE remains possible. | Electrolytes & Acid–Base Emergencies |
| High PCO₂, normal gradient | Pump failure: neuromuscular weakness, drug or brainstem depression, obesity or chest-wall restriction. | Ventilator Management |
| High PCO₂, widened gradient | Combined gas-exchange and ventilatory failure. Assess the cause, titrate oxygen and consider ventilatory support (chapter 4). | Ventilator Management |
A normal resting echocardiogram and a normal chest do not exclude a cardiac contribution. Heart failure with preserved ejection fraction is defined by elevated filling pressures at rest or with provocation, and exertional testing can show what rest does not. Relevant guides: Heart Failure, Echocardiography, Right Heart Cath & Hemodynamics and Cardiopulmonary Exercise Testing.
The 2012 American Thoracic Society statement distinguishes air hunger, breathing effort and chest tightness, which can arise through different mechanisms. Dyspnea engages cortico-limbic networks as well as sensory and motor pathways. A normal gas does not make the symptom unreal. Ask about air hunger, effort and chest tightness, what provokes them, and how they limit activity.